| Literature DB >> 25064673 |
Holly L Hutton1, Mari L DeMarco2, Alex B Magil2, Paul Taylor3.
Abstract
Leukocyte chemotactic factor 2 (LECT2) amyloidosis is a recently identified type of amyloidosis that may represent an underdiagnosed cause of chronic kidney disease. LECT2 amyloidosis typically is reported as being renal limited and, in the United States, more prevalent in Hispanic patients. We add to the epidemiologic data of this condition by describing 4 First Nations people from Northern British Columbia, Canada, who presented with slowly progressive chronic kidney disease that was found to be due to LECT2 amyloidosis.Entities:
Keywords: First Nations; Leukocyte chemotactic factor 2 (LECT2); North American indigenous ancestry; amyloid; amyloidosis; chronic kidney disease (CKD); chronic renal failure
Mesh:
Substances:
Year: 2014 PMID: 25064673 DOI: 10.1053/j.ajkd.2014.06.017
Source DB: PubMed Journal: Am J Kidney Dis ISSN: 0272-6386 Impact factor: 8.860